342 related articles for article (PubMed ID: 31053083)
1. In vitro and in vivo activities of DW-3-15, a commercial praziquantel derivative, against Schistosoma japonicum.
Wang X; Yu D; Li C; Zhan T; Zhang T; Ma H; Xu J; Xia C
Parasit Vectors; 2019 May; 12(1):199. PubMed ID: 31053083
[TBL] [Abstract][Full Text] [Related]
2. Synergistic effect of combination chemotherapy with praziquantel and DW-3-15 for Schistosoma japonicum in vitro and in vivo.
Yang ZY; Liu ZH; Zhang YN; Li C; Liu L; Pu WJ; Xie SQ; Xu J; Xia CM
Parasit Vectors; 2021 Oct; 14(1):550. PubMed ID: 34702326
[TBL] [Abstract][Full Text] [Related]
3. [Studies on resistance of Schistosoma to praziquantel XIII resistance of Schistosoma japonicum to praziquantel is experimentally induced in laboratory].
Liang YS; Li HJ; Dai JR; Wang W; Qu GL; Tao YH; Xing YT; Li YZ; Qian K; Wei JY
Zhongguo Xue Xi Chong Bing Fang Zhi Za Zhi; 2011 Dec; 23(6):605-10. PubMed ID: 22379812
[TBL] [Abstract][Full Text] [Related]
4. A comparison of the antischistosomal effect of levo- and dextro-praziquantel on Schistosoma japonicum and S. mansoni in mice.
Tanaka M; Ohmae H; Utsunomiya H; Nara T; Irie Y; Yasuraoka K
Am J Trop Med Hyg; 1989 Aug; 41(2):198-203. PubMed ID: 2505624
[TBL] [Abstract][Full Text] [Related]
5. [Studies on resistance of Schistosoma to praziquantel XIV experimental comparison of susceptibility to praziquantel between PZQ-resistant isolates and PZQ-susceptible isolates of Schistosoma japonicum in stages of adult worms, miracidia and cercariae].
Li HJ; Liang YS; Dai JR; Wang W; Qu GL; Li YZ; Xing YT; Tao YH; Qian K; Jia Y; Yang ZK; Wei JY
Zhongguo Xue Xi Chong Bing Fang Zhi Za Zhi; 2011 Dec; 23(6):611-9. PubMed ID: 22379813
[TBL] [Abstract][Full Text] [Related]
6. Small change, big difference: A promising praziquantel derivative designated P96 with broad-spectrum antischistosomal activity for chemotherapy of schistosomiasis japonica.
Xu J; Dong LL; Sun H; Huang P; Zhang RZ; Wang XY; Sun DQ; Xia CM
PLoS Negl Trop Dis; 2023 Jul; 17(7):e0011215. PubMed ID: 37410790
[TBL] [Abstract][Full Text] [Related]
7. Schistosoma japonicum and S. mansoni: ultrastructural damage in the tegument and reproductive organs after treatment with levo- and dextro-praziquantel.
Irie Y; Utsunomiya H; Tanaka M; Ohmae H; Nara T; Yasuraoka K
Am J Trop Med Hyg; 1989 Aug; 41(2):204-11. PubMed ID: 2505625
[TBL] [Abstract][Full Text] [Related]
8. Schistosoma japonicum-infected hamsters (Mesocricetus auratus) used as a model in experimental chemotherapy with praziquantel, artemether, and OZ compounds.
Xiao SH; Mei JY; Jiao PY
Parasitol Res; 2011 Feb; 108(2):431-7. PubMed ID: 20922422
[TBL] [Abstract][Full Text] [Related]
9. Praziquantel promotes protection against Schistosoma japonicum infection in mice.
Shao B; Gui X; Lu Z; Lv R; Li H; Lu K; Hong Y; Fu Z; Jin Y; Lin J; Fei C; Liu J
Acta Trop; 2023 May; 241():106874. PubMed ID: 36863502
[TBL] [Abstract][Full Text] [Related]
10. Transdermal praziquantel administration attenuates hepatic granulomatosis in mice infected with Schistosoma japonicum.
Li-zhi W; Xin-Sheng Z; Jiang-shan D; Yi W; Bao-an Y
Parasitol Res; 2015 Apr; 114(4):1417-24. PubMed ID: 25630695
[TBL] [Abstract][Full Text] [Related]
11. Efficacy of administration of praziquantel on 2 days 2 weeks apart against Schistosoma japonicum eggs in mice.
Hirose Y; Kirinoki M; Matsuda H
Parasitol Int; 2003 Jun; 52(2):141-6. PubMed ID: 12798925
[TBL] [Abstract][Full Text] [Related]
12. Effect of combined treatment with praziquantel and artemether on Schistosoma japonicum and Schistosoma mansoni in experimentally infected animals.
Utzinger J; Chollet J; You J; Mei J; Tanner M; Xiao S
Acta Trop; 2001 Sep; 80(1):9-18. PubMed ID: 11495639
[TBL] [Abstract][Full Text] [Related]
13. Efficacy of artemether and artesunate in mice infected with praziquantel non-susceptible isolate of Schistosoma japonicum.
Wang W; Li TY; Ji Y; Qu GL; Qian YL; Li HJ; Dai JR; Liang YS
Parasitol Res; 2014 Mar; 113(3):925-31. PubMed ID: 24326467
[TBL] [Abstract][Full Text] [Related]
14. [Studies on resistance of
Ke Q; You-Sheng L; Wei W; Guo-Li Q; Hong-Jun L; Zhen-Kun Y; Zheng-Yang Z; Yuntian X; Jian-Rong D
Zhongguo Xue Xi Chong Bing Fang Zhi Za Zhi; 2017 Dec; 29(6):683-688. PubMed ID: 29469443
[TBL] [Abstract][Full Text] [Related]
15. Praziquantel derivatives exhibit activity against both juvenile and adult Schistosoma japonicum.
Duan WW; Qiu SJ; Zhao Y; Sun H; Qiao C; Xia CM
Bioorg Med Chem Lett; 2012 Feb; 22(4):1587-90. PubMed ID: 22264473
[TBL] [Abstract][Full Text] [Related]
16. Is there a reduced sensitivity of dihydroartemisinin against praziquantel-resistant Schistosoma japonicum?
Wang W; Li HJ; Qu GL; Xing YT; Yang ZK; Dai JR; Liang YS
Parasitol Res; 2014 Jan; 113(1):223-8. PubMed ID: 24146208
[TBL] [Abstract][Full Text] [Related]
17. Oxadiazole-2-oxides may have other functional targets, in addition to SjTGR, through which they cause mortality in Schistosoma japonicum.
Song LJ; Luo H; Fan WH; Wang GP; Yin XR; Shen S; Wang J; Jin Y; Zhang W; Gao H; Liu Q; Wang WL; Feng B; Yu CX
Parasit Vectors; 2016 Jan; 9():26. PubMed ID: 26791563
[TBL] [Abstract][Full Text] [Related]
18. [Experiment of praziquantel rectal administration in treatment of schistosomiasis in mice].
Yang Y; Wang JM; Jiang Y; Li XH; Liu Y; Zhu CG; Shi YJ
Zhongguo Xue Xi Chong Bing Fang Zhi Za Zhi; 2011 Dec; 23(6):674-6, 686. PubMed ID: 22379825
[TBL] [Abstract][Full Text] [Related]
19. Adverse effects of praziquantel treatment of Schistosoma japonicum infection: involvement of host anaphylactic reactions induced by parasite antigen release.
Matsumoto J
Int J Parasitol; 2002 Apr; 32(4):461-71. PubMed ID: 11849642
[TBL] [Abstract][Full Text] [Related]
20. Niosomes for enhanced activity of praziquantel against Schistosoma mansoni: in vivo and in vitro evaluation.
Zoghroban HS; El-Kowrany SI; Aboul Asaad IA; El Maghraby GM; El-Nouby KA; Abd Elazeem MA
Parasitol Res; 2019 Jan; 118(1):219-234. PubMed ID: 30421348
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
